240 related articles for article (PubMed ID: 30342962)
1. Docosahexaenoic acid protection in a rotenone induced Parkinson's model: Prevention of tubulin and synaptophysin loss, but no association with mitochondrial function.
Serrano-García N; Fernández-Valverde F; Luis-Garcia ER; Granados-Rojas L; Juárez-Zepeda TE; Orozco-Suárez SA; Pedraza-Chaverri J; Orozco-Ibarra M; Jiménez-Anguiano A
Neurochem Int; 2018 Dec; 121():26-37. PubMed ID: 30342962
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of a standardized extract of Centella asiatica ECa233 in rotenone-induced parkinsonism rats.
Teerapattarakan N; Benya-Aphikul H; Tansawat R; Wanakhachornkrai O; Tantisira MH; Rodsiri R
Phytomedicine; 2018 May; 44():65-73. PubMed ID: 29895494
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.
Abdin AA; Hamouda HE
Neuropharmacology; 2008 Dec; 55(8):1340-6. PubMed ID: 18817789
[TBL] [Abstract][Full Text] [Related]
4. Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats.
Karuppagounder SS; Madathil SK; Pandey M; Haobam R; Rajamma U; Mohanakumar KP
Neuroscience; 2013 Apr; 236():136-48. PubMed ID: 23357119
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
Parkhe A; Parekh P; Nalla LV; Sharma N; Sharma M; Gadepalli A; Kate A; Khairnar A
Neurosci Lett; 2020 Jan; 716():134652. PubMed ID: 31778768
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum.
Chitre NM; Wood BJ; Ray A; Moniri NH; Murnane KS
Neuropharmacology; 2020 May; 167():107976. PubMed ID: 32001239
[TBL] [Abstract][Full Text] [Related]
7. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin protects MES23.5 cells against rotenone via inhibiting mitochondrial dysfunction and apoptosis.
Yu J; Xu H; Shen X; Jiang H
Neuropeptides; 2016 Apr; 56():69-74. PubMed ID: 26459609
[TBL] [Abstract][Full Text] [Related]
9. Thymoquinone exerts neuroprotective effect in animal model of Parkinson's disease.
Ebrahimi SS; Oryan S; Izadpanah E; Hassanzadeh K
Toxicol Lett; 2017 Jul; 276():108-114. PubMed ID: 28526446
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory and neuroprotective effects of natural cordycepin in rotenone-induced PD models through inhibiting Drp1-mediated mitochondrial fission.
Zhang XL; Huang WM; Tang PC; Sun Y; Zhang X; Qiu L; Yu BC; Zhang XY; Hong YX; He Y; Ge XQ
Neurotoxicology; 2021 May; 84():1-13. PubMed ID: 33549657
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial regulation by pyrroloquinoline quinone prevents rotenone-induced neurotoxicity in Parkinson's disease models.
Lu J; Chen S; Shen M; He Q; Zhang Y; Shi Y; Ding F; Zhang Q
Neurosci Lett; 2018 Nov; 687():104-110. PubMed ID: 30240821
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of asiatic acid on rotenone-induced mitochondrial dysfunction and oxidative stress-mediated apoptosis in differentiated SH-SYS5Y cells.
Nataraj J; Manivasagam T; Justin Thenmozhi A; Essa MM
Nutr Neurosci; 2017 Jul; 20(6):351-359. PubMed ID: 26856988
[TBL] [Abstract][Full Text] [Related]
13. Naringin Exhibits Neuroprotection Against Rotenone-Induced Neurotoxicity in Experimental Rodents.
Garabadu D; Agrawal N
Neuromolecular Med; 2020 Jun; 22(2):314-330. PubMed ID: 31916219
[TBL] [Abstract][Full Text] [Related]
14. The Docosanoid Neuroprotectin D1 Induces TH-Positive Neuronal Survival in a Cellular Model of Parkinson's Disease.
Calandria JM; Sharp MW; Bazan NG
Cell Mol Neurobiol; 2015 Nov; 35(8):1127-36. PubMed ID: 26047923
[TBL] [Abstract][Full Text] [Related]
15. Intervention of mitochondrial dysfunction-oxidative stress-dependent apoptosis as a possible neuroprotective mechanism of α-lipoic acid against rotenone-induced parkinsonism and L-dopa toxicity.
Abdin AA; Sarhan NI
Neurosci Res; 2011 Dec; 71(4):387-95. PubMed ID: 21889550
[TBL] [Abstract][Full Text] [Related]
16. Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's disease.
Carriere CH; Kang NH; Niles LP
Brain Res; 2016 Feb; 1633():115-125. PubMed ID: 26740407
[TBL] [Abstract][Full Text] [Related]
17. Nesfatin-1 antagonized rotenone-induced neurotoxicity in MES23.5 dopaminergic cells.
Tan Z; Xu H; Shen X; Jiang H
Peptides; 2015 Jul; 69():109-14. PubMed ID: 25937598
[TBL] [Abstract][Full Text] [Related]
18. Contribution of DHA diols (19,20-DHDP) produced by cytochrome P450s and soluble epoxide hydrolase to the beneficial effects of DHA supplementation in the brains of rotenone-induced rat models of Parkinson's disease.
Oguro A; Ishihara Y; Siswanto FM; Yamazaki T; Ishida A; Imaishi H; Imaoka S
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Feb; 1866(2):158858. PubMed ID: 33279658
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism.
Chiu CC; Yeh TH; Lai SC; Wu-Chou YH; Chen CH; Mochly-Rosen D; Huang YC; Chen YJ; Chen CL; Chang YM; Wang HL; Lu CS
Exp Neurol; 2015 Jan; 263():244-53. PubMed ID: 25263579
[TBL] [Abstract][Full Text] [Related]
20. Improved neuroprotective effect of resveratrol nanoparticles as evinced by abrogation of rotenone-induced behavioral deficits and oxidative and mitochondrial dysfunctions in rat model of Parkinson's disease.
Palle S; Neerati P
Naunyn Schmiedebergs Arch Pharmacol; 2018 Apr; 391(4):445-453. PubMed ID: 29411055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
